WASHINGTON (Reuters) - The Food and Drug Administration's secret monitoring of its staff raised hackles in Congress on Sunday after lawmakers learned their own offices were apparently targeted by the surveillance operation. Six current and former FDA scientists and doctors filed a lawsuit in January claiming the agency tried to repress warnings about potential corruption in device reviews
View the original here:
FDA surveillance operation draws criticism from
Brak komentarzy:
Prześlij komentarz